Moderna
MRNA
675 hedge funds and large institutions have $8.06B invested in Moderna in 2025 Q2 according to their latest regulatory filings, with 91 funds opening new positions, 235 increasing their positions, 219 reducing their positions, and 103 closing their positions.
2.36% more ownership
Funds ownership: 73.13% → 75.49% (+2.4%)
7% more repeat investments, than reductions
Existing positions increased: 235 | Existing positions reduced: 219
1% more capital invested
Capital invested by funds: $8B → $8.06B (+$57.8M)
3% less funds holding
Funds holding: 694 → 675 (-19)
12% less first-time investments, than exits
New positions opened: 91 | Existing positions closed: 103
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
18% less call options, than puts
Call options by funds: $896M | Put options by funds: $1.09B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Advisers
New York
|
+$106M |
| 2 |
Two Sigma Investments
New York
|
+$66M |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$59.3M |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$50.6M |
| 5 |
D.E. Shaw & Co
New York
|
+$48.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$75.2M |
| 2 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$75.2M |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$64.1M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$39.1M |
| 5 |
SAMH
Shanda Asset Management Holdings
Tortola,,
British Virgin Islands
|
-$28.4M |
MRNA Hedge Fund Activity: Q2 2025 in Review
675 of the 7,613 institutional investors tracked by Wall St. Rank reported a position in Moderna (MRNA) for Q2 2025, worth a combined $8.06B — up 0.72% from $8B a quarter earlier.
Sellers outnumbered buyers: 103 funds closed out of MRNA and 91 opened new positions — a net loss of 12 holders — while 219 trimmed existing stakes and 235 added.
The largest buyer was Two Sigma Advisers, adding an estimated $106M. The largest seller was Wellington Management Group, cutting an estimated $75.2M.
- 675 institutional investors held Moderna (MRNA) as of Q2 2025, down from 694 in Q1 2025.
- Funds reported $8.06B of Moderna stock for Q2 2025, up 0.72% quarter-over-quarter.
- 91 funds opened new Moderna positions in Q2 2025 and 103 closed out, a net change of -12 holders.
- The largest Moderna buyer in Q2 2025 was Two Sigma Advisers, an estimated $106M added.
- The largest Moderna seller in Q2 2025 was Wellington Management Group, an estimated $75.2M sold.
Based on aggregated 13F filings for Q2 2025.